PGRMC2 and endometrial cancer: In contrast, 100% of Ptend/d; Pgrmc2d/d mice survived to nine months despite all developing endometrial cancer suggesting the Pgrmc2 not only attenuates tumor growth, but also the likely metastatic spread.